Serum cholesterol concentrations and all-cause mortality in older people
- PMID: 10690699
- DOI: 10.1093/ageing/29.1.69
Serum cholesterol concentrations and all-cause mortality in older people
Abstract
Objective: To study the impact of serum cholesterol concentrations on the total risk of mortality in older people.
Design: Retrospective cohort study with a follow-up of 8-10 years.
Subjects: A total of 989 subjects (367 men and 622 women) aged 65 and over, living in the Marshfield Epidemiologic Study Area at the time of their first complete serum lipid assessment.
Methods: We calculated sex-specific mean levels of serum total cholesterol, low-density lipoprotein, high-density lipoprotein and triglycerides, and the ratio of total cholesterol to high-density lipoprotein, for subjects who died of all causes and for those who survived to the end of follow-up, with adjustment for relevant covariates. We obtained estimates of the risk factor-adjusted sex-specific relative risk for all-cause mortality with approximate quartiles of serum cholesterol concentrations by proportional hazards regression models. We also evaluated the possible combined effects of age, sex and cholesterol on all-cause mortality.
Results: A high level of high-density lipoprotein was significantly associated with a low total risk of mortality in older men. Conversely, an elevated ratio of total cholesterol to high-density lipoprotein was directly related to an increased total risk of mortality in older men. Age and high-density lipoprotein level had a significant synergistic effect on all-cause mortality for the elderly men. We found little or no association in women between all-cause mortality and any of the lipid measures studied.
Conclusions: An increased ratio of total cholesterol to high-density lipoprotein appears to be associated with an increase in risk for all-cause mortality in men aged 65 and over, while an elevated level of high-density lipoprotein, considered alone, seems to be protective against mortality from all causes in men aged 65-74 years, but this effect diminishes over the age of 75.
Similar articles
-
High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.Arch Intern Med. 2003 Jul 14;163(13):1549-54. doi: 10.1001/archinte.163.13.1549. Arch Intern Med. 2003. PMID: 12860577
-
Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.JAMA. 1994 Nov 2;272(17):1335-40. JAMA. 1994. PMID: 7772105
-
Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.Arch Intern Med. 1993 May 10;153(9):1065-73. Arch Intern Med. 1993. PMID: 8481074
-
HDL cholesterol predicts coronary heart disease mortality in older persons.JAMA. 1995 Aug 16;274(7):539-44. JAMA. 1995. PMID: 7629981
-
Serum high-density lipoprotein cholesterol levels and mortality in frail, community-living elderly.Gerontology. 2008;54(2):71-8. doi: 10.1159/000111381. Epub 2007 Nov 15. Gerontology. 2008. PMID: 18025809
Cited by
-
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.BMJ Open. 2016 Jun 12;6(6):e010401. doi: 10.1136/bmjopen-2015-010401. BMJ Open. 2016. PMID: 27292972 Free PMC article.
-
Plasma lipid concentrations and survival in geriatric population: A retrospective cohort study.Medicine (Baltimore). 2019 Dec;98(49):e18154. doi: 10.1097/MD.0000000000018154. Medicine (Baltimore). 2019. PMID: 31804326 Free PMC article.
-
Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III.BMC Public Health. 2012 Oct 23;12:895. doi: 10.1186/1471-2458-12-895. BMC Public Health. 2012. PMID: 23092358 Free PMC article.
-
How lifespan associated genes modulate aging changes: lessons from analysis of longitudinal data.Front Genet. 2013 Jan 22;4:3. doi: 10.3389/fgene.2013.00003. eCollection 2013. Front Genet. 2013. PMID: 23346098 Free PMC article.
-
Variability in the prescription of cardiovascular medications in older patients: correlates and potential explanations.Drugs Aging. 2009 Dec;26 Suppl 1:41-51. doi: 10.2165/11534650-000000000-00000. Drugs Aging. 2009. PMID: 20136168 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical